Rivaroxaban Tablets should not be discontinued on its own. As a new type of oral anticoagulant, rivaroxaban tablets act mainly on coagulation factor Xa factor when anticoagulating. Since rivaroxaban is easy to take and has a low risk of bleeding, and the price has been significantly reduced in recent years, the number of patients taking rivaroxaban tablets for anticoagulation therapy has increased year by year. Currently, rivaroxaban tablets are mainly used for atrial fibrillation, thromboprophylaxis in orthopedic surgery, and symptomatic treatment of lower extremity venous thrombosis. If you wish to discontinue rivaroxaban tablets, the risk of thrombosis needs to be evaluated under the supervision of a specialist. If the risk of embolism is high, discontinuation of rivaroxaban tablets is not recommended. However, if you do not want to continue taking rivaroxaban tablets for personal reasons, you can change to other anticoagulant medications under the guidance of a specialist, and you should not stop the medication on your own.